See also our related blog for the Pediatric Preclinical Testing Initiative.

Sunday, September 16, 2012

2:1 matching dollars for alveolar rhabdomyosarcoma

A pharmaceutical company in the Northeast has offered 2:1 matching dollars to fund research on a kinase inhibitor they make which our lab believes will be of benefit to patients with alveolar rhabdomyosarcoma.  The pharmaceutical company is willing to contribute up to $84,000 to match donations from the community of up to $42,000. 
This particular drug (kinase inhibitor) has a good rationale for being important exclusively in the alveolar subtype of rhabdomyosarcoma, and it is rare that we find a partner in industry willing to advance a drug just for alveolar rhabdomyosarcoma to the clinic.  The basic science studies we would do (preclinical studies) are the prelude to clinical trial studies that the pharmaceutical company would pay for in full (usually a >$2M investment on their part).
For more information, please email Charles at .  

Friday, September 14, 2012

COG Fall 2012 Meeting

This Fall's Children's Oncology Group meeting was energized as the new leadership initiatives to incorporate more and more science into clinical trial design are evolving.  Presentations from our lab and program included:

- Targets of opportunity for rhabdomyosarcoma (soft tissue sarcoma session)
- Ad Hoc Preclinical Consortia to Support Trial Design for DIPG (brain tumor session)
- The Rally Foundation Legacy Gift Pilot Program (pathology session)

as well as research on two STS committee agents of interest.  
Expect an announcement soon on the initiative from the Rally Foundation, one of the leaders in innovative, grassroots childhood cancer research funding. 

Thursday, September 6, 2012

Rally Foundation takes bold step in Pediatric Cancer Research

Stay tuned for a more formal announcement of a $166,000 grant from the Rally Foundation to fund Legacy Gifts (research autopsy opportunities to find new ways to treat the otherwise untreatable 1 in 5 childhood cancers).  Jinu is grateful to be the recipient of this award which brings Legacy Gifts to a national level.